O'Connor Daniel J. is President and CEO of Ambrx Biopharma Inc.
Person profile
Roles
Address
Bedminster, New Jersey
Employees
Former names
O'Connor Daniel
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Ambrx Biopharma, Inc.
7 Mar 24
4
SEELOS THERAPEUTICS, INC.
8 Jan 24
4
Ambrx Biopharma, Inc.
11 Dec 23
144
Ambrx Biopharma, Inc.
1 Nov 23
4
Ambrx Biopharma, Inc.
31 Oct 23
4
Ambrx Biopharma Inc.
7 Jul 23
SC 13D/A
ZyVersa Therapeutics, Inc.
12 May 23
4
Ambrx Biopharma Inc.
28 Apr 23
4
SEELOS THERAPEUTICS, INC.
5 Jan 23
3
Ambrx Biopharma Inc.
3 Jan 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Mar 24 | AMAM Ambrx Biopharma | Common Stock | Sale back to company | Dispose D | No | No | 0 | 48,202 | 0.00 | 0 |
7 Mar 24 | AMAM Ambrx Biopharma | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 16.66 | 173,785 | 2.90 mm | 0 |
7 Mar 24 | AMAM Ambrx Biopharma | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 0.91 | 772,857 | 703.30 k | 0 |
7 Mar 24 | AMAM Ambrx Biopharma | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 750,000 | 0.00 | 0 |
7 Mar 24 | AMAM Ambrx Biopharma | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 294,643 | 0.00 | 0 |
4 Jan 24 | SEEL Seelos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.33 | 1,666 | 2.22 k | 1,666 |
11 Dec 23 | AMAM Ambrx Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 750,000 | 0.00 | 1,363,332 |
27 Oct 23 | AMAM Ambrx Biopharma | Common Stock | Sell | Dispose S | No | Yes | 9.82 | 50,012 | 491.12 k | 342,845 |
26 Apr 23 | AMAM Ambrx Biopharma | Ordinary Shares | Grant | Acquire A | No | No | 0 | 2,750,000 | 0.00 | 2,750,000 |